BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 36509772)

  • 1. Tumor fractions deciphered from circulating cell-free DNA methylation for cancer early diagnosis.
    Zhou X; Cheng Z; Dong M; Liu Q; Yang W; Liu M; Tian J; Cheng W
    Nat Commun; 2022 Dec; 13(1):7694. PubMed ID: 36509772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unintrusive multi-cancer detection by circulating cell-free DNA methylation sequencing (THUNDER): development and independent validation studies.
    Gao Q; Lin YP; Li BS; Wang GQ; Dong LQ; Shen BY; Lou WH; Wu WC; Ge D; Zhu QL; Xu Y; Xu JM; Chang WJ; Lan P; Zhou PH; He MJ; Qiao GB; Chuai SK; Zang RY; Shi TY; Tan LJ; Yin J; Zeng Q; Su XF; Wang ZD; Zhao XQ; Nian WQ; Zhang S; Zhou J; Cai SL; Zhang ZH; Fan J
    Ann Oncol; 2023 May; 34(5):486-495. PubMed ID: 36849097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
    Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
    Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A computational framework to unify orthogonal information in DNA methylation and copy number aberrations in cell-free DNA for early cancer detection.
    Wei Q; Jin C; Wang Y; Guo S; Guo X; Liu X; An J; Xing J; Li B
    Brief Bioinform; 2022 Jul; 23(4):. PubMed ID: 35649341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel cell-free DNA methylation-based model improves the early detection of colorectal cancer.
    Wu X; Zhang Y; Hu T; He X; Zou Y; Deng Q; Ke J; Lian L; He X; Zhao D; Cai X; Chen Z; Wu X; Fan JB; Gao F; Lan P
    Mol Oncol; 2021 Oct; 15(10):2702-2714. PubMed ID: 33694305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid Biopsy of Methylation Biomarkers in Cell-Free DNA.
    Luo H; Wei W; Ye Z; Zheng J; Xu RH
    Trends Mol Med; 2021 May; 27(5):482-500. PubMed ID: 33500194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to detect cancer early using cell-free DNA.
    Hasenleithner SO; Speicher MR
    Cancer Cell; 2022 Dec; 40(12):1464-1466. PubMed ID: 36513047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Value of Circulating Free DNA Integrity and Global Methylation Status in Gall Bladder Carcinoma.
    Kumari S; Husain N; Agarwal A; Neyaz A; Gupta S; Chaturvedi A; Lohani M; Sonkar AA
    Pathol Oncol Res; 2019 Jul; 25(3):925-936. PubMed ID: 29376201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A method for early diagnosis of lung cancer from tumor originated DNA fragments using plasma cfDNA methylome and fragmentome profiles.
    Kim YJ; Jeon H; Jeon S; Lee SH; Kim C; Ahn JH; Um H; Woo YJ; Jeong SH; Kim Y; Park HY; Oh HJ; Cho HJ; Bae JH; Kim JH; An S; Kang SB; Jho S; Biro O; Kis D; Kim BC; Kim Y; Kim JH; Kim BC; Bhak J; Oh IJ
    Mol Cell Probes; 2022 Dec; 66():101873. PubMed ID: 36379302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating cell-free DNA-based methylation pattern in plasma for early diagnosis of esophagus cancer.
    Wang R; Yang Y; Lu T; Cui Y; Li B; Liu X
    PeerJ; 2024; 12():e16802. PubMed ID: 38313016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA.
    Liu MC; Oxnard GR; Klein EA; Swanton C; Seiden MV;
    Ann Oncol; 2020 Jun; 31(6):745-759. PubMed ID: 33506766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of cell-free DNA approaches for multi-cancer early detection.
    Jamshidi A; Liu MC; Klein EA; Venn O; Hubbell E; Beausang JF; Gross S; Melton C; Fields AP; Liu Q; Zhang N; Fung ET; Kurtzman KN; Amini H; Betts C; Civello D; Freese P; Calef R; Davydov K; Fayzullina S; Hou C; Jiang R; Jung B; Tang S; Demas V; Newman J; Sakarya O; Scott E; Shenoy A; Shojaee S; Steffen KK; Nicula V; Chien TC; Bagaria S; Hunkapiller N; Desai M; Dong Z; Richards DA; Yeatman TJ; Cohn AL; Thiel DD; Berry DA; Tummala MK; McIntyre K; Sekeres MA; Bryce A; Aravanis AM; Seiden MV; Swanton C
    Cancer Cell; 2022 Dec; 40(12):1537-1549.e12. PubMed ID: 36400018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and validation of methylation signatures in circulating cell-free DNA for early detection of esophageal cancer: a case-control study.
    Qiao G; Zhuang W; Dong B; Li C; Xu J; Wang G; Xie L; Zhou Z; Tian D; Chen G; Tang J; Zhou H; Zhang D; Shi R; Chen R; Nian W; Zhang Y; Zhao J; Wen X; Xu Y; Li B; Zhang Z; Cai S; Ben X; Qi Y
    BMC Med; 2021 Oct; 19(1):243. PubMed ID: 34641873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation analysis of tumor suppressor genes in liquid biopsy components of early stage NSCLC: a promising tool for early detection.
    Markou Α; Londra D; Tserpeli V; Kollias Ι; Tsaroucha E; Vamvakaris I; Potaris K; Pateras I; Kotsakis Α; Georgoulias V; Lianidou Ε
    Clin Epigenetics; 2022 May; 14(1):61. PubMed ID: 35538556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of methylation status using WGS data of plasma cfDNA for multi-cancer early detection (MCED).
    Cui P; Zhou X; Xu S; He W; Huang G; Xiong Y; Zhang C; Chang T; Feng M; Lai H; Pan Y
    Clin Epigenetics; 2024 Feb; 16(1):34. PubMed ID: 38414068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodal analysis of cell-free DNA whole-methylome sequencing for cancer detection and localization.
    Bie F; Wang Z; Li Y; Guo W; Hong Y; Han T; Lv F; Yang S; Li S; Li X; Nie P; Xu S; Zang R; Zhang M; Song P; Feng F; Duan J; Bai G; Li Y; Huai Q; Zhou B; Huang YS; Chen W; Tan F; Gao S
    Nat Commun; 2023 Sep; 14(1):6042. PubMed ID: 37758728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel sensitive detection method for DNA methylation in circulating free DNA of pancreatic cancer.
    Shinjo K; Hara K; Nagae G; Umeda T; Katsushima K; Suzuki M; Murofushi Y; Umezu Y; Takeuchi I; Takahashi S; Okuno Y; Matsuo K; Ito H; Tajima S; Aburatani H; Yamao K; Kondo Y
    PLoS One; 2020; 15(6):e0233782. PubMed ID: 32520974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole exome sequencing of cell-free DNA - A systematic review and Bayesian individual patient data meta-analysis.
    Bos MK; Angus L; Nasserinejad K; Jager A; Jansen MPHM; Martens JWM; Sleijfer S
    Cancer Treat Rev; 2020 Feb; 83():101951. PubMed ID: 31874446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of genome-wide in cell free DNA methylation: progress and prospect.
    Liu Z; Wang Z; Jia E; Ouyang T; Pan M; Lu J; Ge Q; Bai Y
    Analyst; 2019 Oct; 144(20):5912-5922. PubMed ID: 31436778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer signature ensemble integrating cfDNA methylation, copy number, and fragmentation facilitates multi-cancer early detection.
    Kim SY; Jeong S; Lee W; Jeon Y; Kim YJ; Park S; Lee D; Go D; Song SH; Lee S; Woo HG; Yoon JK; Park YS; Kim YT; Lee SH; Kim KH; Lim Y; Kim JS; Kim HP; Bang D; Kim TY
    Exp Mol Med; 2023 Nov; 55(11):2445-2460. PubMed ID: 37907748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.